Trials / Active Not Recruiting
Active Not RecruitingNCT03900468
Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 140 (estimated)
- Sponsor
- MedtronicNeuro · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this post-approval study is to further evaluate the long-term safety and effectiveness of Medtronic DBS therapy for epilepsy on seizure reduction in newly implanted participants through 3 years of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Activa™ PC and Percept™ PC Neurostimulation Systems | Implanted DBS system consisting of a Neurostimulator, Leads, Extensions, and potential accessories including Burr Hole Devices, Clinician Tablet, Clinician Programmer Therapy Application Software, Clinician Programmer Communicator, Patient Programmer |
Timeline
- Start date
- 2020-03-05
- Primary completion
- 2025-10-15
- Completion
- 2026-03-27
- First posted
- 2019-04-03
- Last updated
- 2026-02-11
Locations
13 sites across 2 countries: United States, Czechia
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03900468. Inclusion in this directory is not an endorsement.